U.S. Tobacco Stock News

Allot (NasdaqGS:ALLT) is set to present at the 2026 Cantor Global Technology & Industrial Growth Conference in New York on March 11, where CEO and President Eyal David Harari will brief investors. See our latest analysis for Allot. Against this backdrop, Allot’s recent share price performance has been weak, with a 30 day share price return of 34.34% and a year to date share price return of 29.92%. At the same time, the 3 year total shareholder return sits at 165.49%, suggesting longer term...

AeroVironment (AVAV) just posted Q3 2026 results with revenue of US$408.0 million and a basic EPS loss of US$3.15, alongside trailing twelve month revenue of about US$1.6 billion and a TTM EPS loss of US$5.15. Over recent quarters, revenue has moved from US$167.6 million in Q3 2025 to US$275.1 million in Q4 2025, then US$454.7 million in Q1 2026, US$472.5 million in Q2 2026 and now US$408.0 million in Q3 2026. Quarterly basic EPS has swung between a profit of US$0.59 and losses ranging from...

InterDigital's Chief Technology Officer has sold company shares, continuing a year-long pattern of insider selling. No insider share purchases at InterDigital, NasdaqGS:IDCC, have been reported over the same period. This activity adds a fresh data point for investors tracking internal sentiment and executive behavior at the company. InterDigital, NasdaqGS:IDCC, focuses on wireless and video technology research, licensing its intellectual property to device makers and network operators. In a...

If you are wondering whether Medline's current share price reflects its true worth, you are not alone. This article will walk through what the numbers say about value. Medline recently closed at US$42.39, with a 1.1% decline over the last 7 days, a 10.5% decline over 30 days, and a 4.4% gain year to date. These moves may suggest the market is still forming a view on the stock. Recent coverage around Medline has focused on its positioning as a healthcare stock and how investors are treating...

Earnings snapshot and dividend update W&T Offshore (WTI) has drawn fresh attention after reporting fourth quarter and full year 2025 results, with lower annual revenue, a larger net loss, and a maintained quarterly dividend. See our latest analysis for W&T Offshore. The latest earnings release and the recent affirmation of the US$0.01 quarterly dividend came alongside a 67.65% 3 month share price return and a 94.69% 1 year total shareholder return. However, the 3 year total shareholder return...

Wondering if Cogent Communications Holdings is now priced attractively or if the share price still does not reflect its fundamentals? This article walks through the key valuation angles to help you frame that question for yourself. The stock closed at US$21.34, with returns of a 7.6% decline over 7 days, a 14.9% decline over 30 days, a 3.5% gain year to date, and a 67.4% decline over 1 year, which naturally raises questions about how the market is reassessing its prospects and risks. Recent...

If you are wondering whether Open Text's share price still reflects its underlying business, you are not alone. This article looks at what the numbers say about value rather than headlines. At a last close of US$23.99, the stock has seen returns of a 4.3% decline over 7 days, a 5.4% decline over 30 days, a 24.4% decline year to date and a 1.6% decline over the past year, with a 25.5% decline over 3 years and a 43.3% decline over 5 years. Recent trading has been shaped by ongoing investor...

Generac Holdings (NYSE:GNRC) received multiple GOOD DESIGN Awards for products in home standby, portable generators, and energy storage systems. The recognition covers several product lines that focus on design, usability, and sustainability. The awards highlight Generac’s efforts to differentiate within the broader energy technology and backup power market. For you as an investor, this recognition ties directly to how Generac positions itself across backup power and energy management. The...

Trump Media & Technology Group (NasdaqGM:DJT) has outlined a pivot toward Bitcoin treasury management as a primary business activity. The company plans to expand its financial assets, introduce bitcoin linked options, and pursue new ventures tied to ETFs and prediction markets. Management has also flagged initiatives in AI powered search and a potential merger related to fusion energy as part of a broader shift beyond the Truth Social platform. For investors following Trump Media &...

If you are wondering whether Vail Resorts is attractively priced after a long slide in the share price, this article walks through what the current valuation might be telling you. The stock last closed at US$138.53, with returns of 1.6% over 7 days, a 1.8% decline over 30 days, a 3.4% gain year to date, and declines of 9.2%, 26.2% and 47.5% over the past 1, 3 and 5 years respectively. Recent news coverage has focused on Vail Resorts as a large operator in the ski and mountain resort space,...

If you are wondering whether Nuvalent at around US$100 a share still offers fair value, you are not alone. This article is built to help you make sense of the current price tag. The stock is roughly flat year to date with a 0.8% decline, but over the last year it has returned 38.0%, and over three years the return is very large. That performance can change how investors think about both upside and risk. Recent headlines around Nuvalent have focused on its progress as a clinical stage...

Director at Lincoln Educational Services (NasdaqGS:LINC) recently executed a sizable share sale, extending a pattern of insider selling. Recent filings show continued insider disposals over time, with no offsetting insider purchases reported. The cluster of sales focuses attention on board sentiment and governance signals that are not visible in headline financials. Lincoln Educational Services, listed on the NasdaqGS under the ticker LINC, operates career-focused education programs that...

SIGA Technologies (SIGA) has just wrapped up FY 2025 with a mixed earnings print, as fourth quarter revenue came in at about US$3.8 million and basic EPS landed at a loss of US$0.08, while the trailing 12 month figures show total revenue of roughly US$94.6 million and basic EPS of US$0.33. The company has seen quarterly revenue move from US$81.5 million in Q4 2024 to US$81.1 million in Q2 2025 before easing back to US$3.8 million in Q4 2025, with EPS shifting from US$0.64 in Q4 2024 to...

Biotech sentiment has improved following an FDA leadership change that investors view as easing regulatory hurdles for cell and gene therapies. PTC Therapeutics, listed as NasdaqGS:PTCT, is among the companies seen as directly affected by this shift in perceived regulatory risk. The change centers on the departure of an official viewed as cautious on accelerated approvals, which is drawing fresh attention to PTC's drug pipeline. For PTC Therapeutics, trading at $65.67, this regulatory...

Kennametal executive Ellen Whittingham has been named a 2026 STEP Ahead Award Honoree. The award recognizes her leadership and work in talent development within the manufacturing sector. This recognition highlights Kennametal's focus on workplace culture and leadership depth at NYSE:KMT. Kennametal, listed on NYSE:KMT, supplies tooling and industrial materials to customers across metalworking and related manufacturing fields. Recognition for an executive focused on leadership and talent...

Blend Labs (BLND) just posted its FY 2025 fourth quarter numbers, with revenue of US$32.4 million and a basic EPS loss of US$0.03, while net income excluding extra items came in at a loss of US$7.1 million. The company has seen quarterly revenue move from US$41.4 million in Q4 2024 to US$32.4 million in Q4 2025, with basic EPS shifting from a loss of US$0.03 in Q4 2024 to a loss of US$0.03 in the latest quarter. As a result, this reporting period is likely to draw attention to how the loss...

If you are wondering whether Strategic Education's current share price still represents solid value, the recent data gives you plenty to think about. The stock closed at US$78.87 recently, with returns of a 3.3% decline over 7 days and a 1.3% decline over 30 days, while year to date it is up 0.4% and the 1-year return sits at 1.6%. These steady but modest return figures over the past year, including 0.8% over 3 years and 4.6% over 5 years, suggest the market has been cautious in how it...

Global Business Travel Group (NYSE:GBTG) has completed its acquisition of CWT, reaching what management calls an inflection point in its business transformation. The company is rolling out Egencia AI, which management says is already contributing to measurable revenue and cost efficiencies. GBTG reports strong revenue growth and profitability in 2025 alongside accelerated integration, restructuring, and productivity efforts. For investors watching NYSE:GBTG, the share price at $5.57 sits...

Lantronix (LTRX) is back on investor radars after expanding its embedded compute portfolio with new MediaTek based System on Module solutions and signing a European distribution deal with Melchioni Electronics. See our latest analysis for Lantronix. The recent MediaTek based SOM launch and the Melchioni distribution deal arrive after a mixed stretch for the stock, with a 7 day share price return of 3.89% but a 90 day share price return decline of 6.69%, while the 1 year total shareholder...

uniQure (NasdaqGS:QURE) faces multiple securities class action lawsuits focused on disclosures around its AMT-130 gene therapy program. Federal health officials have criticized the company for alleged data manipulation tied to AMT-130. The FDA has withdrawn support for a Biologics License Application for AMT-130, complicating the program's regulatory path. Upcoming changes in FDA leadership are expected to affect how AMT-130 and related filings are reviewed. These developments arrive at a...

Servier Pharmaceuticals has entered into a definitive agreement to acquire Day One Biopharmaceuticals, NasdaqGS:DAWN, in an all cash transaction. The deal marks a material change in ownership, bringing Day One Biopharmaceuticals under Servier control and ending its status as an independent company once the transaction closes. Day One Biopharmaceuticals focuses on developing and commercializing oncology therapies, a segment that has seen frequent partnerships, licensing arrangements, and...

Domo (DOMO) closed FY 2026 with fourth quarter revenue of US$79.6 million and a basic EPS loss of US$0.19, setting a clear snapshot of where the top line and bottom line currently stand. Over recent periods the company has kept quarterly revenue in a tight band around US$79 million to US$80 million, while basic EPS losses have ranged from US$0.25 to US$0.56 per quarter, giving investors a consistent read on how revenue scale and per share losses are tracking together. With that backdrop, this...

Transaction Systems Services (TSS) closed its FY 2025 third quarter with revenue of US$41.9 million, Basic EPS of US$0.06 loss and net income excluding extra items of US$1.5 million loss. The trailing twelve months show revenue of US$234.8 million, Basic EPS of US$0.20 and net income of US$4.9 million. Over recent periods, the company has seen quarterly revenue move between US$12.2 million and US$99.0 million, with Basic EPS ranging from US$0.06 loss to US$0.13 per share. Net income excluding...

Kodiak AI (KDK) just wrapped up FY 2025 with Q4 revenue of US$1.1 million and a basic EPS loss of US$0.42. The trailing twelve months show revenue of US$16.5 million and a basic EPS loss of US$5.74. The company reported TTM revenue of US$14.9 million in FY 2024, alongside a basic EPS loss of US$0.79, giving investors a clearer view of how the top line and per share losses have been tracking into this latest result and providing context for the 6.5% revenue growth figure reported over the past...